Abstract
Chronic recurrent multifocal osteomyelitis (CRMO) is a severe form of chronic nonbacterial osteomyelitis (CNO) that affects the long bones as well as other skeletal sites, such as the spine. Gleeson et al. recently described seven patients affected by CRMO who were treated with intravenous pamidronate, and concluded that pamidronate therapy should be considered early in the treatment of CRMO affecting the spine. No nonvertebral effects of pamidronate were noted, indicating that additional anti-inflammatory medication should be used in patients who have vertebral and nonvertebral CNO lesions. Although adverse effects of bisphosphonate therapy on bone have been noted previously, Gleeson et al. only reported undesirable effects such as generalized aches and pains, fever and injection-site reaction. As with previous studies of bisphosphonate treatment of patients with CNO, however, the number of patients included in this study was small (n = 7) and the follow-up was limited; therefore, bisphosphonate treatment of children and adolescents should only be considered as a last resort until controlled trials with long-term follow-up are performed.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO)
Pediatric Rheumatology Open Access 23 December 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Girschick HJ et al. (2005) Chronic non-bacterial osteomyelitis in children. Ann Rheum Dis 64: 279–285
Gleeson H et al. (2008) Childhood chronic recurrent multifocal oseomyelitis: pamidronate therapy decreased pain and improves vertebral shape. J Rheumatol 35: 707–712
Vittecoq O et al. (2000) Evolution of chronic recurrent multifocal osteitis toward spondylarthropathy over the long term. Arthritis Rheum 43: 109–119
Bjorksten B et al. (1978) Chronic recurrent multifocal osteomyelitis and pustulosis palmoplantaris. J Pediatr 93: 227–231
Girschick HJ et al. (2007) Chronic recurrent multifocal osteomyelitis: what is it and how should it be treated? Nat Clin Pract Rheumatol 3: 733–738
Montonen M et al. (2001) Disodium clodronate in the treatment of diffuse sclerosing osteomyelitis (DSO) of the mandible. Int J Oral Maxillofac Surg 30: 313–317
Marshall H et al. (2002) Pamidronate: a novel treatment for the SAPHO syndrome? Rheumatology (Oxford) 41: 231–233
Courtney PA et al. (2002) Treatment of SAPHO with pamidronate. Rheumatology (Oxford) 41: 1196–1198
Dodson TB et al. (2008) Case records of the Massachusetts General Hospital. Case 9–2008. A 65-year-old woman with a nonhealing ulcer of the jaw. N Engl J Med 358: 1283–1291
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Rights and permissions
About this article
Cite this article
Morbach, H., Stenzel, M. & Girschick, H. Bisphosphonate treatment for patients with chronic nonbacterial osteomyelitis. Nat Rev Rheumatol 4, 570–571 (2008). https://doi.org/10.1038/ncprheum0908
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0908
This article is cited by
-
Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO)
Pediatric Rheumatology (2013)